These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33551032)

  • 1. Reply to "Managing T2-high severe asthma in HIV-infected patients".
    Curto E; Torrego A; Garin N; Crespo-Lessmann A; Plaza V
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):1043. PubMed ID: 33551032
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing T2-high severe asthma in HIV-infected patients.
    Terl M; Jesenak M
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):1041-1043. PubMed ID: 33551031
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV-infected patient with severe asthma treated with mepolizumab: Case report.
    Curto E; Torrego A; Garin N; Crespo-Lessmann A; Plaza V
    J Allergy Clin Immunol Pract; 2020; 8(7):2414-2416. PubMed ID: 32272285
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    Boccara F; Rosenson RS;
    J Am Coll Cardiol; 2020 Sep; 76(12):1503-1504. PubMed ID: 32943170
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: To PMID 24679845.
    Long A; Rothman K; Chen H; Carrigan G; Szefler S;
    J Allergy Clin Immunol; 2015 Jan; 135(1):289-90. PubMed ID: 25441293
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-HIV agents. PRO 140--a receptor antibody for HIV.
    TreatmentUpdate; 2007; 19(6):7-8. PubMed ID: 18041151
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
    Singh A; Mittal S; Kazimuddin M
    J Am Coll Cardiol; 2020 Sep; 76(12):1503. PubMed ID: 32943169
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation.
    Efthimiou J; Poll C; Barnes PJ
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31000674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drug for multidrug-resistant HIV.
    Nat Biotechnol; 2018 Apr; 36(4):291. PubMed ID: 29621221
    [No Abstract]   [Full Text] [Related]  

  • 10. Atopic dermatitis is an important comorbidity in severe asthma.
    Lee JK; Han D
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply: Toward Primary Prevention of Asthma: Role of Corticosteroids for the First Rhinovirus Wheeze.
    Hartert T; Hershenson M
    Am J Respir Crit Care Med; 2015 Oct; 192(8):1019-20. PubMed ID: 26469845
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful Use of Dupilumab for Recalcitrant Atopic Dermatitis in an HIV Patient.
    Marks DH; Piantadosi AL; Patil SU; Raff A; Yu J
    Dermatitis; 2019; 30(4):276-277. PubMed ID: 31261222
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.
    Fitzpatrick ME; Kunisaki KM; Morris A
    AIDS; 2018 Jan; 32(3):277-292. PubMed ID: 29194119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma.
    Russell R; Brightling C
    Expert Rev Respir Med; 2016 Jun; 10(6):607-17. PubMed ID: 27058452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection.
    Dhody K; Pourhassan N; Kazempour K; Green D; Badri S; Mekonnen H; Burger D; Maddon PJ
    HIV Clin Trials; 2018 Jun; 19(3):85-93. PubMed ID: 29676212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies for severe asthma (review)].
    Solèr M
    Ther Umsch; 2019 Nov; 76(6):317-321. PubMed ID: 31762416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply.
    Corren J
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):822. PubMed ID: 32037117
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on immunogenicity in severe asthma: Experience with mepolizumab.
    Ortega HG; Meyer E; Brusselle G; Asano K; Prazma CM; Albers FC; Mallett SA; Yancey SW; Gleich GJ
    J Allergy Clin Immunol Pract; 2019; 7(7):2469-2475.e1. PubMed ID: 30954640
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-1 acquisition in a man with ulcerative colitis on anti-α4β7 mAb vedolizumab treatment.
    Gunst JD; Schleimann MH; Pahus MH; Østergaard L; Tolstrup M; Søgaard OS
    AIDS; 2020 Sep; 34(11):1689-1692. PubMed ID: 32769767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.